文献速递心力衰竭与心肌病

慢性阻塞性肺疾病急性加重后长期心血管风险升高

Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease.
PubMed 文献 · Heart · 2024-04-25

结果显示,急性加重后1-7天主要复合终点发生率从加重前5.43/100人年升至95.61/100人年(调整HR 15.86,95%CI 15.17-16.58),其中心力衰竭失代偿风险最高(HR 72.34,95%CI 64.43-81.22),且风险升高持续至1年。

要点

  • 中重度COPD急性加重后1-7天心血管复合终点风险增加约16倍。
  • 心力衰竭失代偿风险最高,1-7天HR达72.34。
  • 风险升高持续至急性加重后1年,重度加重影响更大更持久。

核心结论

  • 中重度COPD急性加重是不良心血管事件的独立危险因素,其中心力衰竭失代偿风险最高。

主要发现

  • 急性加重后1-7天发生率升至95.61/100人年,调整HR 15.86(95%CI 15.17-16.58),且风险升高持续至1年。
  • 中度和重度急性加重后复合及个体心血管事件风险均增加,重度加重后风险更大且更持久。
  • 心力衰竭失代偿风险增幅最大,1-7天HR 72.34(95%CI 64.43-81.22)。

临床怎么用

  • COPD急性加重后应视为心血管高危期,尤其需警惕心力衰竭失代偿。
  • 急性加重后1年内应加强心血管风险评估与监测。

局限性

  • 本研究为回顾性队列研究,基于行政数据,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the risk of adverse cardiovascular (CV) events following an exacerbation of chronic obstructive pulmonary disease (COPD). METHODS: This retrospective cohort study identified patients with COPD using administrative data from Alberta, Canada from 2014 to 2019. Exposure periods were 12 months following moderate or severe exacerbations; the reference period was time preceding a first exacerbation. The primary outcome was the composite of all-cause death or a first hospitalisation for acute coronary syndrome, heart failure (HF), arrhythmia or cerebral ischaemia. Time-dependent Cox regression models estimated covariate-adjusted risks associated with six exposure subperiods following exacerbation. RESULTS: Among 1 42 787 patients (mean age 68.1 years and 51.7% men) 61 981 (43.4%) experienced at least one exacerbation and 34 068 (23.9%) died during median follow-up of 64 months. The primary outcome occurred in 43 564 (30.5%) patients with an incidence rate prior to exacerbation of 5.43 (95% CI 5.36 to 5.50) per 100 person-years. This increased to 95.61 per 100 person-years in the 1-7 days postexacerbation (adjusted HR 15.86, 95% CI 15.17 to 16.58) and remained increased for up to 1 year. The risk of both the composite and individual CV events was increased following either a moderate or a severe exacerbation, though greater and more prolonged following severe exacerbation. The highest magnitude of increased risk was observed for HF decompensation (1-7 days, HR 72.34, 95% CI 64.43 to 81.22). CONCLUSION: Moderate and severe COPD exacerbations are independent risk factors for adverse CV events, especially HF decompensation. The impact of optimising COPD management on CV outcomes should be evaluated.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Hawkins, Nordon, Rhodes, et al. Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease. Heart. 2024. PMID: 38182279. doi:10.1136/heartjnl-2023-323487

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。